Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases

Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases

US Patent 11419850 · Granted Aug 23, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium ant2024
Glycopyrronium fatty acid salts and methods of making same2019
Traffic cone2019
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic t2019
Traffic cone2019
Traffic cone2019
Quaternary ammonium anti-cholinergic muscarinic receptor antagonists2018
Traffic cone2017
Traffic cone2017
Traffic cone2017
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in 2015
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic t2015